|
Alburquerque-Gonzalez B, Montoro-Garcia S, Bernabe-Garcia A, Bernabe-Garcia M, Campioni-Rodrigues P, Rodriguez-Martinez A, Luque I, Salo T, Perez-Garrido A, Perez-Sanchez H, Cayuela ML, Luengo-Gil G, Luchinat E, Postigo-Corrales F, Staderini T, Nicolas FJ, Conesa-Zamora P. Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway. Biomed Pharmacother. 2024 Jun;175:116785. doi: 10.1016/j.biopha.2024.116785. Epub 2024 May 22. Erratum In: Biomed Pharmacother. 2024 Oct;179:117411. doi: 10.1016/j.biopha.2024.117411. PubMed PMID: 38781869.
AÑO: 2024; IF: 7.5
|
38781869
|
Santamarina-Garcia M, Brea-Iglesias J, Bramsen JB, Fuentes-Losada M, Caneiro-Gomez FJ, Vazquez-Bueno JA, Lazare-Iglesias H, Fernandez-Diaz N, Sanchez-Rivadulla L, Betancor YZ, Ferreiro-Pantin M, Conesa-Zamora P, Antunez-Lopez JR, Kawazu M, Esteller M, Andersen CL, Tubio JMC, Lopez-Lopez R, Ruiz-Banobre J. MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles. iScience. 2023 Feb 3;26(3):106127. doi: 10.1016/j.isci.2023.106127. eCollection 2023 Mar 17. PubMed PMID: 36879816; PubMed Central PMCID: PMC9984554.
AÑO: 2023; IF: 4.6
|
|
Asensi-Canto A, Rodriguez-Braun E, Beltran-Videla A, Hurtado AM, Conesa-Zamora P. Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial. Front Oncol. 2023 Sep 29;13:1238464. doi: 10.3389/fonc.2023.1238464. eCollection 2023. Erratum In: Front Oncol. 2024 Apr 16;14:1405306. doi: 10.3389/fonc.2024.1405306. PubMed PMID: 37841433; PubMed Central PMCID: PMC10570506.
AÑO: 2023; IF: 3.5
|
|
Muta Y, Linares JF, Martinez-Ordonez A, Duran A, Cid-Diaz T, Kinoshita H, Zhang X, Han Q, Nakanishi Y, Nakanishi N, Cordes T, Arora GK, Ruiz-Martinez M, Reina-Campos M, Kasashima H, Yashiro M, Maeda K, Albaladejo-Gonzalez A, Torres-Moreno D, Garcia-Solano J, Conesa-Zamora P, Inghirami G, Metallo CM, Osborne TF, Diaz-Meco MT, Moscat J. Enhanced SREBP2-driven cholesterol biosynthesis by PKClambda/iota deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis. Nat Commun. 2023 Dec 13;14(1):8075. doi: 10.1038/s41467-023-43690-5. PubMed PMID: 38092754; PubMed Central PMCID: PMC10719313.
AÑO: 2023; IF: 14.7
|
|
Luengo-Gil G, Conesa-Zamora P. Potential Utility of Induced Translocation of Engineered Bacteria as a Therapeutic Agent for Mounting a Personalized Neoantigen-Based Tumor Immune Response. Glob Chall. 2021 Dec 16;6(3):2100051. doi: 10.1002/gch2.202100051. eCollection 2022 Mar. PubMed PMID: 35284089; PubMed Central PMCID: PMC8902290.
AÑO: 2022; IF: 5.135
|